nature medicine glp-1 GLP-1-directed NMDA receptor antagonism for obesity treatment Research shows GLP-1 drugs are

The active ingredient in Ozempic, semaglutide, is not a controlled substance and typically not part of a drug screening test

Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ

References Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al

And most importantly, talk to your prescribing provider if nausea is severe, persistent, or associated with vomiting, dehydration, severe abdominal pain, or inability to eat or drink

Ann N Y Acad Sci 939:162178 Vogelzangs N, Beekman AT, van Reedt Dortland AK, Schoevers RA, Giltay EJ, de Jonge P, Penninx BW (2014) Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users

The FDA approved Zepbound (tirzepatide) for chronic weight management on November 8, 2023